Company news
Theravance Biopharma, Inc. news in 2024
Theravance Biopharma, Inc.'s news releases, calls and decks from 2024, newest first.
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
December 16, 2024
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
November 11, 2024
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
October 23, 2024
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
October 17, 2024
Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
August 4, 2024
Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
July 21, 2024
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 12, 2024
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
April 28, 2024
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
April 9, 2024
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 25, 2024
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
February 13, 2024
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
January 4, 2024
Calls in 2024
- Theravance Biopharma (NASDAQ:TBPH) Q3 2024 Earnings Call
Nov 12, 2024
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q2 2024 Earnings Call
Aug 5, 2024
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q1 2024 Earnings Call
May 13, 2024
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q4 2023 Earnings Call
Feb 26, 2024
Transcript
Decks in 2024
- Q3 2024 Earnings Presentation
Earnings · 45 slides · Nov 12, 2024
- Investor Presentation (September 2024)
Investor deck · 47 slides · Sep 10, 2024
- Q2 2024 Earnings Presentation
Earnings · 43 slides · Aug 5, 2024
- Q1 2024 Earnings Presentation
Earnings · 44 slides · May 13, 2024
- FY2023 Earnings Presentation
Earnings · 42 slides · Feb 26, 2024